Freek W.A. Verheugt - Concepedia

Author

Freek W.A. Verheugt

Also Known As

F Verheugt, F W A Verheugt, F W Verheugt, F. W. A. VERHEUGT, F. W. A. Verheugt, F.W.A Verheugt, F.W.A. Verheugt, Freek Verheugt, Freek W A Verheugt, Freek W. A. Verheugt

141

Publications

5.7K

Citations

H-Index

Concepts

All Affiliations

OLVG Radboud University Nijmegen Dutch Blood Transfusion Society Clinical Research Institute University of Amsterdam

About

Freek W.A. Verheugt is an author at OLVG specializing in medicine, cardiovascular disease, and cardiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	16	17	1.8K
2	Public Health	9	9	591
3	Health Sciences	3	3	164
4	Allergy	1	1	43
5	Cardiothoracic Surgery	1	1	196

Freek W.A. Verheugt

Publications

4.1K

Citations

H-Index

Page 1

	Year	Citations
Ticagrelor plus aspirin for 1 month, followed by ticagrelor monotherapy for 23 months vs aspirin plus clopidogrel or ticagrelor for 12 months, followed by aspirin monotherapy for 12 months after implantation of a drug-eluting stent: a multicentre, open-label, randomised superiority trial Pascal Vranckx, Marco Valgimigli, Peter Jüni, The Lancet Endovascular TechniqueCardiovascular DiseaseRandomised Superiority TrialLumen-apposing Metal StentPharmacotherapy	2018	761
A Simple Immunofluorescence Test for the Detection of Platelet Antibodies A. E. G. Kr. von dem Borne, Freek W.A. Verheugt, F. Oosterhof, British Journal of Haematology	1978	595
The Detection of Granulocyte Alloantibodies with an Indirect Immunofluorescence Test Freek W.A. Verheugt, A. E. G. Kr. von dem Borne, Francine Décary, British Journal of Haematology	1977	292
International trends in clinical characteristics and oral anticoagulation treatment for patients with atrial fibrillation: Results from the GARFIELD-AF, ORBIT-AF I, and ORBIT-AF II registries Benjamin A. Steinberg, Haiyan Gao, Peter Shrader, American Heart Journal	2017	207
Peri-operative management of antiplatelet therapy in patients with coronary artery disease Marco Cattaneo, Pierre‐Guy Chassot, Sabine Eichinger, Thrombosis and Haemostasis Adult Cardiac SurgeryCoronary Artery DiseaseAcute Myocardial InfarctionThrombosisAntiplatelet Agents	2011	196
Management and clinical outcomes in patients treated with apixaban vs warfarin undergoing procedures David García, John H. Alexander, Lars Wallentin, Blood	2014	168
Autoimmune Granulocytopenia: the Detection of Granulocyte Autoantibodies with the Immunofluorescence Test Freek W.A. Verheugt, A. E. G. Kr. von dem Borne, J. C. van Noord‐Bokhorst, British Journal of Haematology	1978	144
Bak<sup>a</sup>, a New Platelet‐Specific Antigen Involved in Neonatal Allo‐Immune Thrombocytopenia A. E. G. Kr. von dem Borne, E Riesz, Freek W.A. Verheugt, Vox Sanguinis	1980	137
Improved risk stratification of patients with atrial fibrillation: an integrated GARFIELD-AF tool for the prediction of mortality, stroke and bleed in patients with and without anticoagulation Keith A.A. Fox, Joseph E. Lucas, Karen S. Pieper, BMJ Open	2017	134
Left ventricular thrombus incidence and behavior studied by serial two-dimensional echocardiography in acute anterior myocardial infarction: left ventricular wall motion, systemic embolism and oral anticoagulation Albert J. Funke Küpper, Freek W.A. Verheugt, Cathinka H. Peels, Journal of the American College of Cardiology Pulmonary EmbolismThrombosisCardiovascular DiseaseMyocardial InfarctionSystemic Embolism	1989	130

Page 1